Tke
First, thank you.
Second, your welcome. So many knowledgeable posters 10 years ago taught me so much, I try and give back where I can
Third, I’m not sure we disagree on much. I think adding AD to the Board is much needed and helpful to get where I want Amarin to go - which is to be bought by Novartis, Pfizer, any BP willing to pay. I DONT agree with a majority on the Board which would make Amarin Denner’s own personal company and retail will no longer be of any value or significance to him. A BO is many months away regardless of who is running the company so people need to realize that no matter what there is a limited amount of cash moving forward and AD won’t change that (unless he brings in a $100M private loan to fund marketing at reasonable interest- that would ideal).
I want the company sold
I want AD on the Board
A BO won’t happen for months, and Amarin has to continue to do what it is doing until the BO (GIA until it isn’t).
KM slashed expenses (fired 90% of salespeople) so what will AD do different
They have to keep moving on coverage and pricing ROW (KM did amazingly in UK, you can’t argue that)
Germany was 100% a case of they just don’t want to pay for new drugs at the moment because of “austerity measures” - not Amarin’s or KM fault (they are NOT waiting for MITIGATE data)
When generics enter the US market the brand usually lose 90% market share within first year. Amarin still holds 60% which is a miracle and entirely due to KM signing deals with insurance.
The US market will only decline from here.
FDC will not help US market loss
US patents are absolutely worthless. The HN lawsuit was our last hope. (The fact it is confidential is pretty standard)
You can’t sell a company that nobody wants to buy unless you drop the price so low the buyer feels there is nothing to lose. AD pushing for an earlier sale just means he is willing to take a lower price (THIS IS ADMITTEDLY JMO).
Bottom line: I want AD on the Board just not more than 2-3 seats (every seat will cost half million share dilution)
No matter who takes over the next couple months don’t change
I don’t see what AD really has to offer besides shareholder representation
WS will probably like AD being added so it will help SP short term
BO will happen sooner with AD IMO but I am not in a rush and think a better price would be achieved if the company matured a bit more (you never get the best price when you are weak and openly desperate to be bought)
Right now Amarin reeks of desperation
News 
Market Data 
Discover 
AI
